Literature DB >> 26916453

Successful Preoperative Chemoembolization in the Treatment of a Giant Malignant Phyllodes Tumor.

Kazuki Hashimoto1, Hidefumi Mimura2, Yasunori Arai2, Masatomo Doi3, Yasuyuki Kojima4, Koichiro Tsugawa4, Yasuo Nakajima2.   

Abstract

The malignant phyllodes tumor is a relatively rare neoplasm and has not previously been a therapeutic target of interventional radiology. Herein, we report a successful case of preoperative chemoembolization of a giant malignant phyllodes tumor. The objective was to achieve sufficient tumor shrinkage before surgery to avoid the requirement for skin grafting after resection. Intra-arterial epirubicin infusion and subsequent embolization with Embosphere Microspheres (BioSphere Medical, Rockland, MA, USA) was undertaken three times over the course of 6 weeks and was well tolerated. The patient underwent surgery without skin grafting. Neither local recurrence nor distant metastasis was observed at 6 months after surgery.

Entities:  

Keywords:  Embosphere Microspheres; Epirubicin; Intra-arterial chemoembolization; Malignant phyllodes tumor; Neoadjuvant chemotherapy; Preoperative chemoembolization

Mesh:

Substances:

Year:  2016        PMID: 26916453     DOI: 10.1007/s00270-016-1311-8

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Preoperative interventional artery embolization for the treatment of a giant malignant phyllodes tumor: A case report.

Authors:  Yue Tian; Linlin Liu; Liang Chen; Shengdi Zhao; Ruijun Su; Wenzhu Zhang; Aimei Jiang; Wenlin Chen; Fei Ge
Journal:  Mol Clin Oncol       Date:  2021-05-11

2.  The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study.

Authors:  Alicja Urbaniak; Fariba Jousheghany; Youzhong Yuan; Sergio Piña-Oviedo; Adam Huczyński; Magdalena Delgado; Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi; Timothy C Chambers
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

3.  Effect of Lipodox in combination with bevacizumab in a patient with a metastatic malignant phyllodes breast tumor: A case report.

Authors:  Chin Cheng Su; Chih-Jung Chen; Shou-Jen Kuo
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.